CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Dexcom G6 continuous glucose monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04569240
NCT04569240N/ACompleted

Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardiac Surgery

The Cleveland Clinic·interventional·Posted Sep 29, 2020·Updated Nov 10, 2025

In Brief

A clinical study evaluating Dexcom G6 continuous glucose monitor for Surgery--Complications. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a prospective longitudinal study to study the agreement between a novel continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the cardiovascular intensive care unit (CVICU), and by point of care glucose using the Accuchek Inform II on the regular floors, and the CGMS at the same time will be captured. Subjects will have measurements taken throughout their stay in the CVICU and on the regular floors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 29, 2020
Enrollment StartMay 1, 2021
Primary CompletionJan 20, 2024
Study CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 5.8 years ago

Interventions

Dexcom G6 continuous glucose monitordevice

Dexcom G6 continuous glucose monitor will be applied to the upper outer arm before cardiovascular surgery. Data will be collected for 10 days or upon discharge from the ICU.